AU1919592A - Method of treating trichotillomania and onychophagia - Google Patents
Method of treating trichotillomania and onychophagiaInfo
- Publication number
- AU1919592A AU1919592A AU19195/92A AU1919592A AU1919592A AU 1919592 A AU1919592 A AU 1919592A AU 19195/92 A AU19195/92 A AU 19195/92A AU 1919592 A AU1919592 A AU 1919592A AU 1919592 A AU1919592 A AU 1919592A
- Authority
- AU
- Australia
- Prior art keywords
- onychophagia
- trichotillomania
- treating
- treating trichotillomania
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68575291A | 1991-04-16 | 1991-04-16 | |
US685752 | 1991-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1919592A true AU1919592A (en) | 1992-11-17 |
Family
ID=24753533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19195/92A Abandoned AU1919592A (en) | 1991-04-16 | 1992-04-16 | Method of treating trichotillomania and onychophagia |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1919592A (en) |
WO (1) | WO1992018005A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6512010B1 (en) | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
US6203817B1 (en) | 1997-02-19 | 2001-03-20 | Alza Corporation | Reduction of skin reactions caused by transdermal drug delivery |
IL152330A0 (en) | 1997-07-01 | 2003-05-29 | Pfizer | Sertraline salts and sustained-release dosage forms of sertraline |
AR021155A1 (en) | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | TREATMENT OF NEUROTIC DISORDERS |
EP1487460A2 (en) | 2002-02-28 | 2004-12-22 | A & D Bioscience, Inc. | Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof |
ES2515092T3 (en) | 2003-12-11 | 2014-10-29 | Sunovion Pharmaceuticals Inc. | Combination of a sedative and a neurotransmitter modulator and methods of improving sleep quality and treating depression |
WO2011069075A2 (en) | 2009-12-04 | 2011-06-09 | Grant Jon E | Treating impulse control disorders with catechol-o- methyl-transferase inhibitors |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
MX2017013902A (en) | 2015-04-27 | 2018-03-16 | Arena Pharm Inc | 5-ht2c receptor agonists and compositions and methods of use. |
EA039412B1 (en) | 2015-07-31 | 2022-01-25 | Арена Фармасьютикалз, Инк. | 5-ht2c receptor agonists and compositions and methods of use |
EA038219B1 (en) | 2016-08-19 | 2021-07-26 | Арена Фармасьютикалз, Инк. | 5-ht2c receptor agonists and compositions and method of use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5008262A (en) * | 1988-04-19 | 1991-04-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of treating trichotillomania and onchyphagia |
-
1992
- 1992-04-16 WO PCT/US1992/003125 patent/WO1992018005A1/en active Application Filing
- 1992-04-16 AU AU19195/92A patent/AU1919592A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1992018005A1 (en) | 1992-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9119557D0 (en) | Method of treating hair | |
AU5896194A (en) | Anti-diarrheic product and method of treating rotavirus-associated infection | |
AU6947494A (en) | Filter and method of forming | |
IL103772A0 (en) | Bloodbag and method of making same | |
AU8011694A (en) | Casket and method of making same | |
AU1111492A (en) | Method of treating type i diabetes | |
AU1919592A (en) | Method of treating trichotillomania and onychophagia | |
AU1111592A (en) | Method of treating type i diabetes | |
AU8192691A (en) | Method of treatment and compositions therefore | |
AU3730093A (en) | Methods of treating diabetes | |
AU2685892A (en) | Method of treating blood | |
AU617252B2 (en) | Method of treating tinea | |
AU4104093A (en) | Method and compositions for treatment of pyonecrotic processes | |
GB9218027D0 (en) | Novel method of treatment | |
AU5149793A (en) | Method of preparing aminoalkylhydantoins and aminoalkyl-alpha-aminoacids | |
GB9202196D0 (en) | Method of treatment | |
AU2348492A (en) | Method of treating asthma | |
GB9113125D0 (en) | Carton and method of manufacture thereof | |
AU4652393A (en) | Plant treating composition and methods of making and using same | |
CS61691A2 (en) | Composition for dung-water treatment and method of dung-water treatment | |
RU2000769C1 (en) | Method of treating acute and chronic mieloleucosis | |
GB9201391D0 (en) | Method of treatment | |
AU663369B2 (en) | Method of treating GAR-transformylase-dependent tumors | |
AU5015493A (en) | Method of treating asthma | |
GB9218597D0 (en) | Novel method of treatment |